ArticleJournal of managed care & specialty pharmacy2020
Add-On Therapies in Cardiovascular Disease: Reviewing ICER's Report and the Potential Effect on Payers.
Jonathan W Magness et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.